Like most small public companies, Abiomed Corp., a $73 million medical device maker, must meet all the same Sarbanes-Oxley internal control compliance requirements as most large public companies—but with quite fewer resources.

Like most small public companies, Abiomed Corp., a $73 million medical device maker, must meet all the same Sarbanes-Oxley internal control compliance requirements as most large public companies—but with quite fewer resources.
Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,... More by Jaclyn Jaeger